Normal saline and epinephrine — Competitive Intelligence Brief

Normal saline and epinephrine (Normal saline and epinephrine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic amine and crystalloid fluid. Area: Emergency Medicine / Critical Care.

marketed Sympathomimetic amine and crystalloid fluid Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors Emergency Medicine / Critical Care Small molecule

Target snapshot

Normal saline and epinephrine (Normal saline and epinephrine) — Le Bonheur Children's Hospital. Normal saline provides fluid resuscitation and volume expansion, while epinephrine acts as a sympathomimetic agonist to increase heart rate, blood pressure, and cardiac output.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Normal saline and epinephrine TARGET	Normal saline and epinephrine	Le Bonheur Children's Hospital	marketed	Sympathomimetic amine and crystalloid fluid	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Ephedrine, bolus	Ephedrine, bolus	University of Parma	marketed	Sympathomimetic amine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
IM epinephrine 1:1000	IM epinephrine 1:1000	University of Louisville	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Epinephrin 0.01	Epinephrin 0.01	Kasr El Aini Hospital	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
High-dose epinephrine	High-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
cardiac output changes with "ephedrine"	cardiac output changes with "ephedrine"	University Tunis El Manar	marketed	Sympathomimetic amine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
epinephrine perfusion	epinephrine perfusion	Central Hospital, Nancy, France	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic amine and crystalloid fluid class)

1. Le Bonheur Children's Hospital · 1 drug in this class